Table 4.
MICs of tetracycline, tigecycline, macrolides (erythromycin, azithromycin) telithromycin, chloramphenicol, rifampicin and linezolid against F. tularensis.
| Reference | Origin | Nb of strains Type/biovar | Tetracycline | Tigecycline | Erythromycin | Azithromycin | Telithromycin | Chloramphenicol | Rifampicin | Linezolid | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Range | MIC90 | Range | MIC90 | Range | MIC90 | Range | MIC90 | Range | Range | MIC90 | Range | MIC90 | Range | MIC90 | |||
| BROTH MICRODILUTION | |||||||||||||||||
| Origgi et al., 2014 | Switzerland | 19 B6 | ≤ 0.25 | ≤ 0.25 | 2-8 | 4 | ≤ 2 | ≤ 2 | |||||||||
| 5 B12 | ≤ 0.25 | >32 | ≤ 2 | ||||||||||||||
| Georgi et al., 2012 | Europe | 69 B | ≤ 0.125–2 | 1 | 1->16 | >16 | 1–4 | 2 | ≤ 0.5–2 | ||||||||
| North America | 7 A | ≤ 0.125–0.5 | ≤ 0.5 | ||||||||||||||
| Central Asia | 4 ssp. mediasiatica | 0.25–2 | 1–4 | ||||||||||||||
| Urich and Petersen, 2008 | North America | 92 A | 0.25–2 | 1 | 0.5–4 | 2 | 0.5–4 | 2 | |||||||||
| 77 B | 0.12–2 | 1 | 0.5–2 | 0.5 | 0.5–4 | 2 | |||||||||||
| E-TEST MIC STRIPS | |||||||||||||||||
| Johansson et al., 2000 | Sweden | 7 B | >256 | 0.25 | 0.5 | ||||||||||||
| Hotta et al., 2013 | Japan | 36 B | 0.094–1.5 | 1.5 | |||||||||||||
| Kreizinger et al., 2013 | Hungary | 29 B12 | 0.19–0.72 | 0.5 | 0.094–0.19 | 0.19 | >256 | >256 | 0.5–1.5 | 1.5 | 0.5–2 | 1 | 12–48 | 32 | |||
| Yeşilyurt et al., 2011 | Turkey | 39 B biovar II | 0.125–0.5 | 0.38 | 0.094–0.38 | 0.25 | >256 | >256 | >256 | >256 | 0.094–0.25 | 0.25 | 0.25–1 | 0.75 | 0.5–2 | 1.5 | |
| Tomaso et al., 2005 | Austria | 50 B biovar II | 0.125–0.75 | 0.75 | 4->256 | >256 | 0.023–2 | 0.75 | 0.25–3 | 1.5 | |||||||
| Ikäheimo et al., 2000 | Finland | 38 B | 0.094–0.5 | 0.38 | >256 | >256 | 0.125–0.5 | 0.38 | 0.094–0.38 | 0.25 | |||||||
| Kiliç et al., 2013 | Turkey | 249 B biovar II+ 1 biovar japonica | 0.094–0.5 | 0.38 | 1->256 | >256 | 0.094–0.75 | 0.5 | 0.125–1 | 0.75 | |||||||
| Johansson et al., 2002 | USA | 8 A | 0.125–1 | 0.125–2 | 0.5–1 | 0.25–2 | 2–4 | ||||||||||
| 16 B | 0.125–1 | 1 | 0.064–2 | 1 | 0.25–1 | 1 | 0.125–1 | 1 | 4–16 | 8 | |||||||
| Velinov et al., 2011 | Bulgaria | 21 B biovar II | >256 | >256 | 1–4 | 2 | |||||||||||
| AGAR DILUTION | |||||||||||||||||
| Valade et al., 2008 | France | 71 B | 0.125–0.25 | 0.25–2 | 0.015–0.5 | ||||||||||||
| Johansson et al., 2000 | Sweden | 7B | 0.5–1 | 1 | |||||||||||||